The information you are about to be referred to may not comply with the Australian regulatory requirements.  Further information relevant to the Australian environment is available from the company or via the Product Information.

Date of Preparation: July 2017 | AUS/HIV/0060/17

About Us

  • Australia
  • Belgium
  • Canada (English)
  • Canada (Français)
  • Deutschland
  • España
  • France
  • Italia
  • Netherlands
  • Portugal
  • Switzerland
  • United Kingdom
  • United States
  • 日本
    • See more countries
ViiV Healthcare Exchange ViiV Healthcare Exchange ViiV Healthcare Exchange
  • Report an Adverse Event
  • Report an Adverse Event
  • About Us
  • HOME
  • OUR MEDICINES
    • DOVATO
      • Full Product Information
    • TIVICAY WITH LAMIVUDINE
      • Full 3TC Product Information
    • JULUCA
      • Full Product Information
    • TRIUMEQ
      • Full Product Information
    • CABENUVA
      • Full Product Information
    • TIVICAY
      • Full Product Information
    • Kivexa
      • Full Product Information
    • RUKOBIA
      • Full Product Information
    • VOCABRIA
      • Full Product Information
  • MEDICAL EDUCATION
  • MEDICAL AFFAIRS
    • Report an adverse event
    • Medical information enquiries
  • EVENTS
  • CABENUVA
  • Search

Copyright 2020 ViiV Healthcare Pty Ltd – All Rights Reserved.

Trademarks are owned or licensed to the ViiV Healthcare group of companies. ©2020 ViiV Healthcare group of companies or its licensor.

Registered Office Level 3, 436 Johnston Street, Abbotsford, VIC 3067, ACN 138 687 448 | For product information regarding ViiV Healthcare products or to report an adverse event, please contact GSK Medical Information on 1800 499 226

  • ViiV Healthcare.com
  • ViiV Healthcare.com.au
  • Privacy Policy
  • Terms and Conditions
  • Contact us
  • Site Map
  • Accessibility

Date of Preparation: September 2021 | PM-AU-CBR-WCNT-210005  

Back to Top